Close

Press Releases

Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The USFDA's Office of Orphan Drug...

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

Live from Porte De Versailles, Paris: Pharmapack Europe 2025 (January 22–23) selects six start-ups from its 26 strong field of innovators to receive the Pharmapack Europe ‘heart of pharma’. A special commendation given to these early-stage companies advancing new breakthrough...

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock™ Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product for US START-UP INITIATION WINNER Active Label for non-electric smart...

Zerion Pharma and Aché collaborate to exploit the Dispersome® technology for the improvement of two marketed drug products

Zerion Pharma< A/S (“ZERION”) today announces a partnership with Aché Laboratorios Farmacêuticos S.A. (“ACHÉ”), a major Brazilian pharmaceutical company. The partnership is aimed at taking advantage of ZERION’s expertise and its Dispersome® technology for improving the formulation of two drug products in the...

DFE Pharma appoints Sven Abend as new CEO

Goch, Germany - DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced today that Dr. Sven Abend has been appointed as the new Chief Executive Officer (CEO). With 25 years of global business leadership experience, Abend will succeed Martti Hedman and assume his responsibilities on February 1st....

At Pharmapack Europe, Schreiner MediPharm to Present Innovative Cap-Lock Label for Prefilled Syringes

Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will present an innovative solution for the secure, blister-free packaging of syringes at Pharmapack Europe, January 22-23 in Paris. Together with partnering...

Aragen secures $100 Mn investment from Quadria Capital

Hyderabad, India and Singapore: Aragen, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has secured a $100 Mn investment from Quadria Capital, an Asia healthcare-focused Private Equity fund. The investment will result in Quadria acquiring a minority stake in Aragen, at an approximate valuation of USD...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read